- Open Access
- Open Peer Review
Inadequate description of educational interventions in ongoing randomized controlled trials
Trials volume 13, Article number: 63 (2012)
The registration of clinical trials has been promoted to prevent publication bias and increase research transparency. Despite general agreement about the minimum amount of information needed for trial registration, we lack clear guidance on descriptions of non-pharmacologic interventions in trial registries. We aimed to evaluate the quality of registry descriptions of non-pharmacologic interventions assessed in ongoing randomized controlled trials (RCTs) of patient education.
On 6 May 2009, we searched for all ongoing RCTs registered in the 10 trial registries accessible through the World Health Organization International Clinical Trials Registry Platform. We included trials evaluating an educational intervention (that is, designed to teach or train patients about their own health) and dedicated to participants, their family members or home caregivers. We used a standardized data extraction form to collect data related to the description of the experimental intervention, the centers, and the caregivers.
We selected 268 of 642 potentially eligible studies and appraised a random sample of 150 records. All selected trials were registered in 4 registers, mainly ClinicalTrials.gov (61%). The median [interquartile range] target sample size was 205 [100 to 400] patients. The comparator was mainly usual care (47%) or active treatment (47%). A minority of records (17%, 95% CI 11 to 23%) reported an overall adequate description of the intervention (that is, description that reported the content, mode of delivery, number, frequency, duration of sessions and overall duration of the intervention). Further, for most reports (59%), important information about the content of the intervention was missing. The description of the mode of delivery of the intervention was reported for 52% of studies, the number of sessions for 74%, the frequency of sessions for 58%, the duration of each session for 45% and the overall duration for 63%. Information about the caregivers was missing for 70% of trials. Most trials (73%) took place in the United States or United Kingdom, 64% involved only one centre, and participating centers were mainly tertiary-care, academic or university hospitals (51%).
Educational interventions assessed in ongoing RCTs of educational interventions are poorly described in trial registries. The lack of adequate description raises doubts about the ability of trial registration to help patients and researchers know about the treatment evaluated in trials of education.
The International Committee of Medical Journal Editors (ICMJE) has promoted the registration of clinical trials to meet the challenge of research transparency, including the ability to adequately address publication bias and selective reporting, and reduce the amount of wasted research [1–4]. Since 2005, the ICMJE has required registration of all clinical trials as a condition of consideration for publication .
At present, agreement exists on the minimum protocol information that should be registered for a trial, that is, the 20-item World Health Organization (WHO) Trial Registration Data Set ,. One item of this dataset is devoted to the intervention. However, recommendations for the reporting of this item focus on pharmacologic treatments. No clear guidance is provided for descriptions of non-pharmacologic interventions in trial registries.
Nevertheless, reporting non-pharmacologic treatments is important but difficult. Non-pharmacologic interventions, such as educational interventions, are usually complex interventions involving several components  and so are difficult to describe, standardize, reproduce and administer consistently to all patients . In addition, these interventions usually strongly depend on the context of care, such as the care provider’s expertise .
The frequency of noncommunicable diseases is increasing, and determining ways to support people with chronic illness is a strong focus of healthcare agendas . Patient education through various educational interventions plays an essential role for adequately understanding and managing chronic diseases . Thus, results from a growing number of randomized controlled trials (RCTs) assessing educational interventions have been published in the last 10 years and currently represent about 20% of the published results of RCTs .
We aimed to evaluate the quality of descriptions of interventions assessed in RCTs registered in the WHO International Clinical Trials Registry Platform (ICTRP). We focused on descriptions of the intervention and the context of care in the field of patient education.
On 6 May 2009, we searched for all ongoing RCTs assessing an educational intervention that were registered in the 10 registries accessible by the WHO search portal : Australian New Zealand Clinical Trials Registry, Chinese Clinical Trial Register, ClinicalTrials.gov, Clinical Trials Registry – India, German Clinical Trials Register, Iranian Registry of Clinical Trials, ISRCTN.org, Sri Lanka Clinical Trials Registry, The Netherlands National Trial Register and EU Clinical Trials Register. We used this platform because it allows access to all primary registries meeting the WHO criteria. We searched for the intervention “education” for ongoing trials currently recruiting subjects.
Eligibility criteria were an ongoing randomized clinical trial (recorded as “randomized” or described as randomized in the description of the intervention), evaluating an educational intervention (that is, designed to teach or train patients concerning their own health ) and dedicated to participants (healthy or sick), their family members or home caregivers. We excluded interventions involving health workers if the intervention was integrally delivered to them and curative interventions designed to treat mental disorders, such as psychotherapy.
Two reviewers independently screened all potentially eligible studies. All disagreements were resolved by consensus and with a third reviewer if necessary.
From the selected records, we randomly chose a sample of 150 records (50%).
We developed a data extraction form and two reviewers (CP, IB) independently tested it with a sample of 20 studies. The agreement rate between the reviewers ranged from 0.7 to 1.
Then, a single reviewer (CP) used the standardized data extraction form to collect data from 1) the record in the WHO International Clinical Trials Registry Platform, 2) the record in the primary registry (for example, ClinicalTrials.gov, Netherlands National Trial, Australian New Zealand Clinical Trials Registry (…)) and 3) the website included in the record or previous publications listed in the record. All materials mentioned were searched. We did not search the Internet or write to the investigators for additional data. We collected the following data.
We recorded the primary registry, date of registration, study design, comparator, sample size, number of arms and number of experimental arms. We also noted the type of patients enrolled (healthy or sick), mode of recruitment, age of study participants, and centres involved (country, number of centers, type of center).
To determine the number of participating centers, we used the number of centers reported, if any, in the general description of the trial or the number of centers mentioned in the WHO record; or in the primary registry record in the field “Location” (for ClinicalTrials.gov), “Contact’s address” (for ISRCTN.org and Netherlands National Trial), and “Contact person” (for Australian New Zealand Clinical Trials Registry). We considered that the number was not reported if we could not find at least one result in the fields mentioned above. We classified the trial “unclear multicentric” if the term multicentric was used to describe the trial with no details on the centers involved.
We recorded the type of intervention (for example, programmed interaction with a therapist, Web-based program, use of educational material (DVD, booklet) or other type of intervention), and the involvement of other people closely related to the patient in the educational intervention.
We assessed whether items related to the intervention were reported according to the recommendations of the Consort Statement extension for trials of non-pharmacologic treatment . We first determined whether qualitative data were reported and whether the record included information on the mode of delivery (for example, group or individual), care providers and how the intervention was standardized. We determined whether the content of educational sessions was 1) clearly described (that is, all key components reported), 2) available in a publication or on a website referenced in the record, or 3) not reported (that is, many important pieces of information were missing).
We assessed the reporting of quantitative data, such as the number, frequency and duration of sessions and the course period (that is, the period when participants received the intervention).
If several interventions were assessed, we reported the best-described intervention in the data extraction form.
We used descriptive statistics for continuous variables: median [interquartile range], minimum and maximum values. Categorical variables were described with frequencies and percentages. Data analyses involved use of R for Windows, release 2. 9.
Figure 1 describes the trial selection process. We selected 268 of 642 potentially eligible ongoing studies, then randomly selected and appraised 150 studies (56% of the eligible sample).
Participants and setting
All selected trials were registered in four registers, mainly ClinicalTrials.gov (60.7%). The median target sample size was 205 [100 to 400] patients. The comparator(s) were mainly usual care (47%) or an active treatment (47%). Of these, most concerned other educational interventions .
Study characteristics are summarized in Table 1. In total, 70 trials (47%) were taking place in the United States and 38 (26%) in Europe; no study involved low-income countries. When centres were reported, most trials (64%) involved only one centre. Participating centres were mainly tertiary-care, academic or university hospitals (51%).
Most studies (84%) used programmed interaction (that is, education sessions or phone calls); 30% used educational material (that is, DVD or booklet) and 11% an Internet program (Table 2). Of 150 interventions studies, 38 (25%) involved other people closely related to the participant.
A minority of records (17%, 95% CI 11 to 23%) reported an overall adequate description of the intervention (that is, description that reported the content, mode of delivery, number, frequency, duration of sessions and overall duration of the intervention. For most reports, qualitative data were not reported. For 88 (59%) studies, the content of the educational sessions was not reported. The content was clearly described for 30% (n = 45) of the studies and the description of the content was available in a publication for 28% (n = 42). In total, 11% (n = 17) of reports referenced a website that provided access to educational materials; none of the other 89% of reports provided additional materials.
Information about the care providers administering the intervention was available for 30% (n = 44) of the trials and methods of standardization were specified for 7% (n = 9).
The mode of intervention delivery was reported for 52% (n = 65) of the studies, the number of sessions for 74% (n = 100), the frequency of sessions for 58% (n = 78), the duration of each session for 45% (n = 61) and the overall duration of the intervention for 63% (n = 94) (Tables 3 and 4).
This study assessed information included in trial registration for a representative random sample of 150 ongoing RCTs assessing an educational intervention, a non-pharmacologic treatment, in the WHO International Clinical Trial Registry Platform. For most trials (59%), interventions were insufficiently described in terms of educational content, modes of delivery and care providers’ qualifications. Most trials (73%) took place in the United States or the United Kingdom, 64% involved only one centre, and participating centres were mainly tertiary-care, academic or university hospitals (51%). The lack of adequate description in such trials raises doubts about the ability of trial registration to help patients and researchers know about the treatment evaluated.
Prospectively registering clinical trials, by placing key protocol information about the trial in the public domain, has been promoted to prevent misconduct in trials, specifically selective reporting . The lack of adequate reporting of the interventions in registries raises several problems for patients, clinicians and researchers. First, knowing precisely the content of an experimental intervention is a preliminary step for patients who wish to participate in an ongoing trial. As well, clinicians and researchers need to have a clear description of interventions that are currently assessed when they plan new trials. Finally, researchers performing meta-analyses need to precisely identify ongoing studies meeting their inclusion criteria.
Our findings may be explained in part by the lack of consideration of the specifics of non-pharmacologic interventions in guidelines for trial registration. For example, guidelines for the item dedicated to the intervention in the WHO Trial Registration Data Set are “If the intervention consists of several separate treatments, list them all (e.g., "low-fat diet, exercise"). For each intervention, describe other intervention details as applicable (dose, duration, mode of administration, etc.)”. These recommendations are appropriate for drugs but not for non-pharmacologic treatments. Indeed, educational interventions are complex, involve several components  and are, therefore, difficult to describe, standardize, reproduce .
Space constraints in both scientific journals and trial registration databases may restrict the full reporting of interventions . Potential solutions to providing complete descriptions include Internet hyperlinks to additional information and educational materials, establishing a stable “intervention bank” where materials and procedures are made available  and the use of graphics to depict the flow and timing of sessions of treatment .
However, the complete reporting of items in trial registries raises issues related to intellectual property. Research teams that developed these interventions have invested time and money and are entitled to protect their data before the publication of the study results.
Our results are consistent with those of previous studies investigating the quality of reporting in trial registries , [24–26]. As well, previous studies demonstrated inadequate descriptions of non-pharmacologic treatment in published articles , [27–29]. Glasziou et al.. reported that about 70% of reports of trials evaluating non-pharmacologic treatment provided insufficient information on the intervention to allow for replication in practice.
The inferences from this study are limited by the inherent limitations of trial registries. The search strategy may not have identified all studies evaluating educational interventions. Registries have limited advanced search capabilities; contrary to search strategies for databases of published articles, such as MEDLINE or the Cochrane Central Register of Controlled Trials, search strategies of registries have not been evaluated. In addition we did not write to the investigators for clarification.
We show that educational interventions assessed in ongoing RCTs are poorly described in trial registration. The lack of adequate description raises doubt about the ability of trial registration to help patients and researchers know the treatment evaluated.
International Committee of Medical Journal Editors
World Health Organization
Consolidation of the standards of reporting trials
Randomized controlled trials
International Clinical Trials Registry Platform.
De Angelis CD, Drazen JM, Frizelle FA, Haug C, Hoey J, Horton R, Kotzin S, Laine C, Marusic A, Overbeke AJ, Schroeder TV, Sox HC, Van Der Weyden MB: Is this clinical trial fully registered? A statement from the International Committee of Medical Journal Editors. Haematologica. 2006, 91: 293-295.
Dwan K, Altman DG, Arnaiz JA, Bloom J, Chan AW, Cronin E, Decullier E, Easterbrook PJ, Von Elm E, Gamble C, Ghersi D, Ioannidis JP, Simes J, Williamson PR: Systematic review of the empirical evidence of study publication bias and outcome reporting bias. PLoS One. 2008, 3: e3081-10.1371/journal.pone.0003081.
Scherer RW, Langenberg P, von Elm E: Full publication of results initially presented in abstracts. Cochrane Database Syst Rev. 2007, 18 (2): MR000005-
Chalmers I, Glasziou P: Avoidable waste in the production and reporting of research evidence. Lancet. 2009, 374: 86-89. 10.1016/S0140-6736(09)60329-9.
WHO: New standards for registration of human medical research. World Health Organization international clinical trials registry platform. 2006, World Health Organization, Geneva,http://www.who.int/mediacentre/news/rele?ases/2006/pr25/en/,
Laine C, Horton R, DeAngelis CD, Drazen JM, Frizelle FA, Godlee F, Haug C, Hébert PC, Kotzin S, Marusic A, Sahni P, Schroeder TV, Sox HC, Van der Weyden MB, Verheugt FW: Clinical trial registration: looking back and moving ahead. Lancet. 2007, 369: 1909-1911. 10.1016/S0140-6736(07)60894-0.
Hutchinson L: Evaluating and researching the effectiveness of educational interventions. BMJ. 1999, 318: 1267-1269. 10.1136/bmj.318.7193.1267.
Boutron I, Moher D, Altman DG, Schulz KF, Ravaud P: Extending the CONSORT statement to randomized trials of nonpharmacologic treatment: explanation and elaboration. Ann Intern Med. 2008, 148: 295-309.
Halm EA, Lee C, Chassin MR: Is volume related to outcome in health care? A systematic review and methodologic critique of the literature. Ann Intern Med. 2002, 137: 511-520.
WHO: Reducing Risks, Promoting Healthy Life. 2002, WHO Report, Geneva
Coster S, Norman I: Cochrane reviews of educational and self-management interventions to guide nursing practice: a review. Int J Nurs Stud. 2009, 46: 508-528. 10.1016/j.ijnurstu.2008.09.009.
Hopewell S, Dutton S, Yu LM, Chan AW, Altman DG: The quality of reports of randomised trials in 2000 and 2006: comparative study of articles indexed in PubMed. BMJ. 2010, 340: c723-10.1136/bmj.c723.
World Health Organization: International Clinical Trials Registration Platform Search Portal. http://apps.who.int/trialsearch/Trial.aspx?TrialID=NCT01231620. Accessed on May 6, 2009.
Pino C, Boutron I, Ravaud P: Outcomes in registered ongoing Randomized Controlled Trials in patient education. Submitted to Plos One. 2011
Arthritis Self-Management Education Program. NCT00467064. http://clinicaltrials.gov/show/NCT00467064. Accessed on May 6, 2009.
Evaluation of an Online Fatigue Self-management Group Intervention for Adults with Multiple Sclerosis. ACTRN12608000553370. http://www.anzctr.org.au/ACTRN12608000553370.aspx. Accessed on May 6, 2009.
Evaluation of a post-discharge education and support package for stroke clients and their carers: Randomised control trial (Does providing information after stroke help?). ACTRN12608000469314. http://www.anzctr.org.au/ACTRN12608000469314.aspx. Accessed on May 6, 2009.
A trial of a non-medical treatment for menopausal symptoms in women with breast cancer MENOS1. ISRCTN13771934. http://isrctn.org/ISRCTN13771934 Accessed on May 6, 2009.
Meeting the information needs and improving the quality of life of patients beginning chemotherapy treatment. ACTRN12606000178549. http://www.anzctr.org.au/ACTRN12606000178549.aspx. Accessed on May 6, 2009.
Randomised control trial of an internet-based outpatient cardiac rehabilitation program eOCR. ACTRN12609000166279. http://www.anzctr.org.au/ACTRN12609000166279.aspx Accessed on May 6, 2009.
Viergever RF, Ghersi D: The quality of registration of clinical trials. PLoS One. 2011, 6: e14701-10.1371/journal.pone.0014701.
Glasziou P, Chalmers I, Altman DG, Bastian H, Boutron I, Brice A, Jamtvedt G, Farmer A, Ghersi D, Groves T, Heneghan C, Hill S, Lewin S, Michie S, Perera R, Pomeroy V, Tilson J, Shepperd S, Williams JW: Taking healthcare interventions from trial to practice. BMJ. 2010, 341: c3852-10.1136/bmj.c3852.
Perera R, Heneghan C, Yudkin P: Graphical method for depicting randomised trials of complex interventions. BMJ. 2007, 334: 127-129. 10.1136/bmj.39045.396817.68.
Liu X, Li Y, Yu X, Feng J, Zhong X, Yang X, Li J: Assessment of registration quality of trials sponsored by China. J Evid Based Med. 2009, 2: 8-18. 10.1111/j.1756-5391.2009.01007.x.
Moja LP, Moschetti I, Nurbhai M, Compagnoni A, Liberati A, Grimshaw JM, Chan AW, Dickersin K, Krleza-Jeric K, Moher D, Sim I, Volmink J: Compliance of clinical trial registries with the World Health Organization minimum data set: a survey. Trials. 2009, 10: 56-10.1186/1745-6215-10-56.
Zarin DA, Tse T, Ide NC: Trial Registration at ClinicalTrials.gov between May and October 2005. N Engl J Med. 2005, 353: 2779-2787. 10.1056/NEJMsa053234.
Glasziou P, Meats E, Heneghan C, Shepperd S: What is missing from descriptions of treatment in trials and reviews?. BMJ. 2008, 336: 1472-1474. 10.1136/bmj.39590.732037.47.
Warsi A, Wang PS, LaValley MP, Avorn J, Solomon DH: Self-management education programs in chronic disease: a systematic review and methodological critique of the literature. Arch Intern Med. 2004, 164: 1641-1649. 10.1001/archinte.164.15.1641.
Weingarten SR, Henning JM, Badamgarav E, Knight K, Hasselblad V, Gano A, Ofman JJ: Interventions used in disease management programmes for patients with chronic illness-which ones work? Meta-analysis of published reports. BMJ. 2002, 325: 925-10.1136/bmj.325.7370.925.
We thank Laura Smales who edited this manuscript.
The authors declare that they have no competing interests.
CP participated in the study concept and design, the literature search and identifying relevant trial records and the acquisition of data from included records; performed the statistical analysis; and participated in the analysis and interpretation of data and drafted the manuscript. IB participated in the study concept and design, the literature search and identifying relevant systematic reviews, the analysis and interpretation of data, the critical revision of the manuscript for important intellectual content and the study supervision. PR participated in the study concept and design, the analysis and interpretation of data and the critical revision of the manuscript for important intellectual content; and supervised the study. CP is guarantor and has full access to all of the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis. All authors read and approved the final manuscript.
This study was funded by a grant “Recherche infirmière – offre de formation doctorat” of the “Assistance Publique - Hôpitaux de Paris”.
About this article
- Educational Intervention
- Trial Registry
- Zealand Clinical Trial Registry
- International Clinical Trial Registry Platform
- German Clinical Trial Register